Stephanie Lim is a highly experienced professional in the field of immunology and virology. As a Study Director at Artemis Bioservices since March 2020, Stephanie manages projects focusing on the immunogenicity and efficacy of viral vaccines and antiviral candidates for biotech and pharmaceutical clients. Prior to this role, Stephanie worked as a Post-doc at ARTEMIS ONE HEALTH from January 2015 to March 2020 and as a PhD student at Erasmus MC from November 2010 to November 2014, conducting significant research on West Nile virus pathogenesis and vaccine efficacy. Stephanie's early career included internships at GSK, Utrecht Institute of Pharmaceutical Sciences, and the Department of Medical Microbiology at the University Medical Centre Utrecht. Educational credentials include a Master of Science in Immunity and Infection and a Bachelor of Science in Biology, both from Utrecht University.
Artemis Bioservices (formerly known as Artemis Bio-Support)
Artemis Bioservices is a private, non-profit CRO specialized in vaccine and antiviral evaluation. Vision of Artemis Bioservices: The vision of Artemis Bioservices is to become a strategic partner in the process of antiviral, antibody and vaccine development against emerging viral diseases. Mission of Artemis Bioservices: To assist biotech and biopharmaceutical companies to accelerate the development and licensing of safe and effective antiviral intervention strategies, in particular against emerging, zoonotic and arboviral diseases, by offering customized in-vitro testing and in-vivo immunogenicity and efficacy testing capabilities Artemis Bioservices provides high quality preclinical and clinical services to developers of antiviral intervention strategies who want to evaluate the immunogenicity and efficacy of candidate products, especially against emerging, vector-borne and zoonotic viruses. Artemis Bioservices has recently been certified GLP compliant. Artemis Bioservices is located in the Yes!Delft Labs building, at Molengraaffsingel 10, 2629 JD, Delft, The Netherlands.